Healthy volunteers help Fine-Tune minzasolmin tablet absorption
NCT ID NCT06533475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study involved 18 healthy adults to see how a new tablet version of the drug minzasolmin is absorbed compared to an older capsule form, and whether food changes absorption. Participants took single doses under fasting or fed conditions. The study is complete and focused on drug levels in the blood, not on treating any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Minzasolmin (UCB0599)
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Up0152 1001
Berlin, Germany